Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

LEAP THERAPEUTICS, INC. (LPTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/25/2023 4 Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 17,500 options to buy @ $2.21, valued at $38.7k
08/25/2023 4 LI WILLIAM (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 15,000 options to buy @ $2.21, valued at $33.2k
08/25/2023 4 Martin Patricia A. (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 15,000 options to buy @ $2.21, valued at $33.2k
08/25/2023 4 LAWLOR AUGUSTINE (COO) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 70,000 options to buy @ $2.21, valued at $154.7k
08/25/2023 4 Mashiach Nissim (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 15,000 options to buy @ $2.21, valued at $33.2k
08/25/2023 4 Richard Christian M (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 15,000 options to buy @ $2.21, valued at $33.2k
08/25/2023 4 Mirabelli Christopher (Chairman of the Board) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 70,000 options to buy @ $2.21, valued at $154.7k
08/25/2023 4 ONSI DOUGLAS E (CEO,CFO,Pres.,GC,Treas.,&Sec.) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 140,000 options to buy @ $2.21, valued at $309.4k
08/25/2023 4 Schilsky Richard (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 15,000 options to buy @ $2.21, valued at $33.2k
08/25/2023 4 CAVANAUGH JAMES H (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 15,000 options to buy @ $2.21, valued at $33.2k
08/25/2023 4 Granfield Christine (VP, Head of Reg Affairs/Qual) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 70,000 options to buy @ $2.21, valued at $154.7k
08/25/2023 4 O'Mahony John Mark (Chief Manufacturing Officer) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 70,000 options to buy @ $2.21, valued at $154.7k
08/25/2023 4 Baum Jason (Chief Scientific Officer) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 70,000 options to buy @ $2.21, valued at $154.7k
08/25/2023 4 Sirard Cynthia (Chief Medical Officer) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 70,000 options to buy @ $2.21, valued at $154.7k
08/25/2023 4 LOSCALZO JOSEPH (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 15,000 options to buy @ $2.21, valued at $33.2k
08/14/2023 8-K Quarterly results
Docs: "Leap Therapeutics Reports Second Quarter 2023 Financial Results"
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/12/2023 8-K Quarterly results
06/09/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
05/25/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting"
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/15/2023 8-K Quarterly results
Docs: "Leap Therapeutics Reports First Quarter 2023 Financial Results"
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/26/2023 8-K Quarterly results
04/21/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
04/14/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/04/2023 4 Mirabelli Christopher (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 500,000 options to buy @ $0.34, valued at $170k
04/04/2023 4 Sirard Cynthia (Chief Medical Officer) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 500,000 options to buy @ $0.34, valued at $170k
04/04/2023 4 O'Mahony John Mark (Chief Manufacturing Officer) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 500,000 options to buy @ $0.34, valued at $170k
04/04/2023 4 Granfield Christine (VP, Head of Reg Affairs/Qual) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 500,000 options to buy @ $0.34, valued at $170k
04/04/2023 4 LOSCALZO JOSEPH (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 150,000 options to buy @ $0.34, valued at $51k
04/04/2023 4 LI WILLIAM (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 150,000 options to buy @ $0.34, valued at $51k
04/04/2023 4 CAVANAUGH JAMES H (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 150,000 options to buy @ $0.34, valued at $51k
04/04/2023 4 Schilsky Richard (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 150,000 options to buy @ $0.34, valued at $51k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy